Serum cathepsin S is associated with decreased insulin sensitivity and the development of type 2 diabetes in a community-based cohort of elderly men

Diabetes Care

Volumn 36, Issue 1, 2013, Pages 163-165

  Jobs, Elisabeth ^a,b   Risérus, Ulf ^c   Ingelsson, Erik ^d   Sundström, Johan ^c   Jobs, Magnus ^b   Nerpin, Elisabet ^a,b   Iggman, David ^c   Basu, Samar ^c,e   Larsson, Anders ^c   Lind, Lars ^c   Ärnlöv, Johan ^a,b  

^a UPPSALA UNIVERSITY   (Sweden)

^b DALARNA UNIVERSITY   (Sweden)

^c UPPSALA UNIVERSITY   (Sweden)

^d KAROLINSKA INSTITUTE   (Sweden)

^e UNIVERSITÉ CLERMONT AUVERGNE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN S;

AGED; ARTICLE; CLINICAL ARTICLE; COMMUNITY CARE; DISEASE ASSOCIATION; DISEASE COURSE; ELDERLY CARE; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME BLOOD LEVEL; FOLLOW UP; HIGH RISK PATIENT; HUMAN; INSULIN RELEASE; INSULIN SENSITIVITY; MALE; MEN'S HEALTH; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; RISK ASSESSMENT;

AGED; CATHEPSINS; DIABETES MELLITUS, TYPE 2; GLUCOSE CLAMP TECHNIQUE; HUMANS; INSULIN; INSULIN RESISTANCE; MALE;

EID: 84872046229     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc12-0494     Document Type: Article

References (15)

1. Li ZY, Wang P, Miao CY. Adipokines in inflammation, insulin resistance and cardiovascular disease. Clin Exp Pharmacol Physiol 2011;38:888-896
2. Taleb S, Lacasa D, Bastard JP, et al. Cathepsin S, a novel biomarker of adiposity: relevance to atherogenesis. FASEB J 2005;19:1540-1542
3. Jobs E, Risérus U, Ingelsson E, et al. Serum cathepsin S is associated with serum C-reactive protein and interleukin-6 independently of obesity in elderly men. J Clin Endocrinol Metab 2010;95:4460-4464
4. HedstrandH. A study ofmiddle-aged men with particular reference to risk factors for cardiovascular disease. Ups J Med Sci Suppl 1975;19:1-61
5. Jobs E, Ingelsson E, Risérus U, et al. Association between serum cathepsin S and mortality in older adults. JAMA 2011;306:1113-1121
6. DeFronzo RA, Tobin JD, Andres R.Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979;237:E214-E223
7. Pollare T, Vessby B, Lithell H. Lipoprotein lipase activity in skeletal muscle is related to insulin sensitivity. Arterioscler Thrombol 1991;11:1192-1203
8. Naour N, Rouault C, Fellahi S, et al. Cathepsins in human obesity: changes in energy balance predominantly affect cathepsin S in adipose tissue and in circulation. J Clin Endocrinol Metab 2010;95:1861-1868
9. Singh B, Saxena A. Surrogate markers of insulin resistance: a review. World J Diabetes 2010;1:36-47
10. Liu J, Ma L, Yang J, et al. Increased serum cathepsin S in patients with atherosclerosis and diabetes. Atherosclerosis 2006;186:411-419
11. Shi GP, Munger JS, Meara JP, Rich DH, Chapman HA. Molecular cloning and expression of human alveolarmacrophage cathepsin S, an elastinolytic cysteine protease. J Biol Chem 1992;267:7258-7262
12. Reddy VY, Zhang QY,Weiss SJ. Pericellular mobilization of the tissue-destructive cysteine proteinases, cathepsins B, L, and S, by human monocyte-derived macrophages. Proc Natl Acad Sci U S A 1995;92:3849-3853
13. Lafarge JC, Naour N, Clément K, Guerre-Millo M. Cathepsins and cystatin C in atherosclerosis and obesity. Biochimie 2010;92:1580-1586
14. Trayhurn P, Wood IS. Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr 2004;92:347-355
15. Gupta S, Singh RK, Dastidar S, Ray A. Cysteine cathepsin S as an immunomodulatory target: present and future trends. Expert Opin Ther Targets 2008;12:291-299